Grant Detail

About

Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.

Grant Name:

Quality Measure to Improve Use of Germline Testing in Ovarian, Pancreatic, and Select Breast and Prostate Cancers

Organization:

Conquer Cancer Foundation of the American Society of Clinical Oncology

Date Awarded:

Aug 2023
Amount:

$422,424
Term:

48 months
Grant ID:

GBMF9901.01
Funding Area:

Patient Care

To support the development and implementation of a quality measure for adherence to national guidelines for germline testing in cancer.

Related Grants

Conquer Cancer Foundation of the American Society of Clinical Oncology (2)

Organization

Conquer Cancer Foundation of the American Society of Clinical Oncology
- amount
  $422,424
- term
  48 months
Learn More
Title
Quality Measure to Improve Use of Germline Testing in Ovarian, Pancreatic, and Select Breast and Prostate Cancers

Date Awarded
Aug 2023
Organization

Conquer Cancer Foundation of the American Society of Clinical Oncology
- amount
  $170,248
- term
  18 months
Learn More
Title
Biomarker and Genomic Testing to Inform Personalized Cancer Diagnosis

Date Awarded
Oct 2020

date	grant	program	term	amount

date Aug 2023	grant Quality Measure to Improve Use of Germline Testing in Ovarian, Pancreatic, and Select Breast and Prostate Cancers	program Patient Care	term 48 months	amount $422,424

date Oct 2020	grant Biomarker and Genomic Testing to Inform Personalized Cancer Diagnosis	program Patient Care	term 18 months	amount $170,248

Help us spread the word.

Creating positive outcomes for future generations.

Recent News